The Liver Disease Diagnostics Market Overview 2025 report reveals that the market size has grown significantly over the past few years, with projections indicating further expansion.
What are the Historical Growth Trends in the Liver Disease Diagnostics Market?
The market size of liver disease diagnostics has experienced significant growth in recent years. It is projected to expand from $36.26 billion in 2024 to $39.05 billion in 2025, with a compound annual growth rate (CAGR) of 7.7%.
What are the 2025 Market Projections: Forecasted Size & Growth Rate for the Liver Disease Diagnostics Industry?
In 2029, the Liver Disease Diagnostics Global Market is projected to reach $52.04 billion, growing at a compound annual growth rate (CAGR) of 7.4%.
Download Your Free Sample of the 2025 Liver Disease Diagnostics Market Report and Uncover Key Trends Now!
What are the Key Growth Drivers Fueling the Liver Disease Diagnostics Market?
The key drivers in the liver disease diagnostics market are:
•Rise in the geriatric population
•Increase in research and development expenditure
•Growth in the number of biopsy procedures and diseases
•Expanded use of telemedicine technology.
Global Market Segmentation: Identifying Major Liver Disease Diagnostics Industry Segments
The liver disease diagnostics market covered in this report is segmented –
1) By Diagnosis Technique: Laboratory Tests, Imaging, Endoscopy, Biopsy, Other Diagnosis Techniques
2) By Disease: Non-Alcoholic Fatty Liver Disease, Non-Alcoholic Steatohepatitis, Fibrosis, Cirrhosis, Hepatocellular Carcinoma, Other Diseases
3) By End Users: Hospitals, Laboratories, Other End Users
Subsegments:
1) By Laboratory Tests: Blood Tests (Liver Function Tests, Hepatitis Panel), Enzyme Tests (ALT, AST, ALP), Genetic Testing, Serological Tests
2) By Imaging: Ultrasound Imaging, CT Scans, MRI, Elastography (FibroScan)
3) By Endoscopy: Esophagogastroduodenoscopy (EGD), Capsule Endoscopy
4) By Biopsy: Liver Biopsy (Needle Biopsy), Fine Needle Aspiration Biopsy, Laparoscopic Biopsy
5) By Other Diagnosis Techniques: Molecular Imaging, Biomarker Testing, Fibrosis Scoring Systems
Pre-order the 2025 Liver Disease Diagnostics Global Market Report for Fast Delivery & Comprehensive Insights!
What are the emerging Trends Shaping the Future of the Liver Disease Diagnostics Market?
The key trends in the liver disease diagnostics market are:
•Personalized medicine is emerging as a significant trend in the liver disease diagnostics market.
•The field is seeing technological advancements in diagnostic kits.
•There are advancements in rapid tests being observed in the market.
•Technological advancements in the broader healthcare sector are also influencing this market.
Who Are the Top Competitors & Leading Players in the Liver Disease Diagnostics Market?
Major players in the liver disease diagnostics market are:
• F. Hoffmann-La Roche Ltd.
• Abbott Laboratories
• Thermo Fisher Scientific Inc.
• Fujifilm Holdings Corporation
• Echosens SA
• Boston Scientific Corporation
• Laboratory Corporation of America Holdings
• Quest Diagnostics Incorporated
• Siemens Healthineers AG
• bioMérieux SA
• Genentech Inc.
• Perspectum Diagnostics Ltd.
• Owlstone Medical Ltd.
• Enterome SA
• Atlentis Therapeutics AG
• 89bio Inc.
• Aligos Therapeutics Inc.
• BioPredictive SAS
• Cosara Diagnostics Pvt. Ltd.
• Hepion Pharmaceuticals Inc.
• HEPQuant LLC
• Aiforia Technologies Plc
Regional Dominance: Which Area Leads the Global Template Market?
North America was the largest region in the liver disease diagnostics market in 2024
